{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:07:00Z","timestamp":1788217620410,"version":"build-2803163510"},"reference-count":183,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Cholangiocarcinoma is an uncommon and highly aggressive biliary tract malignancy with few manifestations until late disease stages. Diagnosis is currently achieved through a combination of clinical, biochemical, radiological and histological techniques. A number of reported cancer biomarkers have the potential to be incorporated into diagnostic pathways, but all lack sufficient sensitivity and specificity limiting their possible use in screening and early diagnosis. The limitations of standard serum markers such as CA19-9, CA125 and CEA have driven researchers to identify multiple novel biomarkers, yet their clinical translation has been slow with a general requirement for further validation in larger patient cohorts. We review recent advances in the diagnostic pathway for suspected CCA as well as emerging diagnostic biomarkers for early detection, with a particular focus on non-invasive approaches.<\/jats:p>","DOI":"10.3389\/fonc.2021.699401","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T15:47:26Z","timestamp":1633016846000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Biliary Strictures and Cholangiocarcinoma \u2013 Untangling a Diagnostic Conundrum"],"prefix":"10.3389","volume":"11","author":[{"given":"Alexander","family":"Ney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Garcia-Sampedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Goodchild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Acedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Fusai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jcmm.13953","article-title":"The Role of Tumour Microenvironment: A New Vision for Cholangiocarcinoma","volume":"23","author":"Chen","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.08.002","article-title":"The Search for Novel Diagnostic and Prognostic Biomarkers in Cholangiocarcinoma","volume":"1864","author":"Macias","year":"2018","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn.2018.03.16","article-title":"Cohort Contributions to Trends in the Incidence and Mortality of Intrahepatic Cholangiocarcinoma","volume":"7","author":"Beal","year":"2018","journal-title":"HepatoBiliary Surg Nutr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2019.1590634","article-title":"Treatment and Survival of Resected and Unresected Distal Cholangiocarcinoma: A Nationwide Study","volume":"58","author":"Strijker","year":"2019","journal-title":"Acta Oncol (Madr)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: The Next Horizon in Mechanisms and Management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-828889","article-title":"The Epidemiology of Cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.51","article-title":"Cholangiocarcinoma: Current Knowledge and Future Perspectives Consensus Statement From the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary Sclerosing Cholangitis\u2013A Comprehensive Review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4251\/wjgo.v2.i11.407","article-title":"Intra-Hepatic and Extra-Hepatic Cholangiocarcinoma: New Insight Into Epidemiology and Risk Factors","volume":"2","author":"Cardinale","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12885-019-5391-0","article-title":"Molecular Pathogenesis of Cholangiocarcinoma","volume":"19","author":"Labib","year":"2019","journal-title":"BMC Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14090","article-title":"Diagnostic and Prognostic Biomarkers in Cholangiocarcinoma","volume":"39","author":"Macias","year":"2019","journal-title":"Liver Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine Compared With Observation in Resected Biliary Tract Cancer (BILCAP): A Randomised, Controlled, Multicentre, Phase 3 Study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/liv.14086","article-title":"Clinical Presentation, Diagnosis and Staging of Cholangiocarcinoma","volume":"39","author":"Forner","year":"2019","journal-title":"Liver Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"100354","DOI":"10.1016\/j.ctarc.2021.100354","article-title":"Neoadjuvant Therapy for Cholangiocarcinoma: A Comprehensive Literature Review","volume":"27","author":"Rizzo","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0987-3","article-title":"Current and Novel Therapeutic Opportunities for Systemic Therapy in Biliary Cancer","volume":"123","author":"Marin","year":"2020","journal-title":"Br J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: Advances in Pathogenesis, Diagnosis, and Treatment","volume":"48","author":"Blechacz","year":"2008","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1159\/000488342","article-title":"Circulating Biomarkers for Cholangiocarcinoma","volume":"36","author":"Loosen","year":"2018","journal-title":"Dig Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4253\/wjge.v8.i3.128","article-title":"Diagnostic and Therapeutic Biomarkers in Pancreaticobiliary Malignancy","volume":"8","author":"Viterbo","year":"2016","journal-title":"World J Gastrointest Endosc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2014.09.017","article-title":"Comparative Effectiveness of Biliary Brush Cytology and Intraductal Biopsy for Detection of Malignant Biliary Strictures: A Systematic Review and Meta-Analysis","volume":"81","author":"Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/his.13408","article-title":"Well-Differentiated Pancreatic Neuroendocrine Tumours (PanNETs) and Poorly Differentiated Pancreatic Neuroendocrine Carcinomas (PanNECs): Concepts, Issues and a Practical Diagnostic Approach to High-Grade (G3) Cases","volume":"72","author":"Singhi","year":"2018","journal-title":"Histopathology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/gutjnl-2018-317817","article-title":"Integrating Next-Generation Sequencing to Endoscopic Retrograde Cholangiopancreatography (ERCP)-Obtained Biliary Specimens Improves the Detection and Management of Patients With Malignant Bile Duct Strictures","volume":"69","author":"Singhi","year":"2020","journal-title":"Gut"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100593","DOI":"10.1016\/j.trre.2020.100593","article-title":"Diagnosis and Management of Benign Biliary Strictures Post Liver Transplantation in Adults","volume":"35","author":"Keane","year":"2021","journal-title":"Transplant Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4367-z","article-title":"Endoscopic Management of Biliary Leaks and Strictures After Living Donor Liver Transplantation: Optimizing Techniques for Successful Management","volume":"62","author":"Elwir","year":"2017","journal-title":"Dig Dis Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrgastro.2015.182","article-title":"Evaluation of Indeterminate Biliary Strictures","volume":"13","author":"Bowlus","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/CEG.S165016","article-title":"Benign Biliary Strictures: Prevalence, Impact, and Management Strategies","volume":"12","author":"Ma","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1148\/radiol.2018172424","article-title":"Management of Biliary Strictures: State-Of-the-Art Review","volume":"289","author":"Kapoor","year":"2018","journal-title":"Radiology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/1477-7819-12-272","article-title":"Percutaneous Transhepatic and Endoscopic Biliary Drainage for Malignant Biliary Tract Obstruction: A Meta-Analysis","volume":"12","author":"Leng","year":"2014","journal-title":"World J Surg Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11257","article-title":"Benign Hilar Bile Duct Strictures Resected as Perihilar Cholangiocarcinoma","volume":"106","author":"Otsuka","year":"2019","journal-title":"Br J Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12957-016-0794-8","article-title":"Individualized Preoperative Planning Using Three-Dimensional Modeling for Bismuth and Corlette Type III Hilar Cholangiocarcinoma","volume":"14","author":"Zeng","year":"2016","journal-title":"World J Surg Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-012-2109-x","article-title":"Surgical Strategies in Patients With Advanced Hilar Cholangiocarcinoma (Klatskin Tumor)","volume":"17","author":"Izbicki","year":"2013","journal-title":"J Gastrointest Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2018.035","article-title":"Diagnosis of Malignant Biliary Stricture: More Is Better","volume":"51","author":"Lee","year":"2018","journal-title":"Clin Endosc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S1479-666X(03)80006-9","article-title":"Incidence of Benign Pathology in Patients Undergoing Hepatic Resection for Suspected Malignancy","volume":"1","author":"Clayton","year":"2003","journal-title":"Surgery"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2016.05.001","article-title":"Detection of Benign Hilar Bile Duct Stenoses \u2013 A Retrospective Analysis in 250 Patients With Suspicion of Klatskin Tumour","volume":"8","author":"Scheuermann","year":"2016","journal-title":"Ann Med Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2019.01.010","article-title":"Morbidity and Mortality After Major Liver Resection in Patients With Perihilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis","volume":"165","author":"Franken","year":"2019","journal-title":"Surgery"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.51","article-title":"Cytologic Predictors of Malignancy in Bile Duct Brushings: A Multi-Reviewer Analysis of 60 Cases","volume":"30","author":"Avadhani","year":"2017","journal-title":"Mod Pathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/2303-9027.193597","article-title":"Endoscopic Retrograde Cholangiopancreatography Versus Endoscopic Ultrasound for Tissue Diagnosis of Malignant Biliary Stricture: Systematic Review and Meta-Analysis","volume":"7","author":"De Moura","year":"2018","journal-title":"Endosc Ultrasound"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1034","article-title":"Diagnostic Approach Using ERCP-Guided Transpapillary Forceps Biopsy or EUS-Guided Fine-Needle Aspiration Biopsy According to the Nature of Stricture Segment for Patients With Suspected Malignant Biliary Stricture","volume":"6","author":"Lee","year":"2017","journal-title":"Cancer Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-bsgcampus.78","article-title":"P3 Improving ERCP Tissue Acquisition in Malignant Strictures With Transpapillary Endobiliary Biopsies. In: Posters","volume":"70","author":"Ahmed","year":"2021","journal-title":"BMJ Publishing Group Ltd Br Soc Gastroenterology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001402","article-title":"Peroral Cholangioscopy With Cholangioscopy-Directed Biopsies in the Diagnosis of Biliary Malignancies: A Systemic Review and Meta-Analysis","volume":"31","author":"Badshah","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2015.09.024","article-title":"Diagnostic Yield of EUS-Guided FNA for Malignant Biliary Stricture: A Systematic Review and Meta-Analysis","volume":"83","author":"Sadeghi","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2013.11.001","article-title":"Fluorescence In Situ Hybridization for Diagnosis of Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis","volume":"79","author":"Navaneethan","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-018-4906-x","article-title":"Role of Fluorescent In Situ Hybridization, Cholangioscopic Biopsies, and EUS-FNA in the Evaluation of Biliary Strictures","volume":"63","author":"Brooks","year":"2018","journal-title":"Dig Dis Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1007\/s10620-020-06335-x","article-title":"Combination of ERCP-Based Modalities Increases Diagnostic Yield for Biliary Strictures","volume":"66","author":"Han","year":"2020","journal-title":"Dig Dis Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/MOG.0000000000000335","article-title":"Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis","volume":"33","author":"Ehlken","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2019.011","article-title":"The Role of Peroral Cholangioscopy in Evaluating Indeterminate Biliary Strictures","volume":"52","author":"Parsa","year":"2019","journal-title":"Clin Endosc"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2000.108969","article-title":"Tumor Vessel: A Valuable Cholangioscopic Clue of Malignant Biliary Stricture","volume":"52","author":"Kim","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31822f3fcd","article-title":"High-Definition Confocal Endomicroscopy of the Common Bile Duct","volume":"46","author":"Shieh","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"498","DOI":"10.5946\/ce.2015.48.6.498","article-title":"Advanced Imaging Technology in Biliary Tract Diseases:Narrow-Band Imaging of the Bile Duct","volume":"48","author":"Choi","year":"2015","journal-title":"Clin Endosc"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4638683","article-title":"Confocal Laser Endomicroscopy in Gastrointestinal and Pancreatobiliary Diseases: A Systematic Review and Meta-Analysis","volume":"2016","author":"Fugazza","year":"2016","journal-title":"BioMed Res Int"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2014.10.009","article-title":"Validation of the Diagnostic Accuracy of Probe-Based Confocal Laser Endomicroscopy for the Characterization of Indeterminate Biliary Strictures: Results of a Prospective Multicenter International Study","volume":"81","author":"Slivka","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1055\/a-1061-7067","article-title":"Limited Diagnostic Accuracy and Clinical Impact of Single-Operator Peroral Cholangioscopy for Indeterminate Biliary Strictures","volume":"52","author":"de Vries","year":"2020","journal-title":"Endoscopy"},{"key":"B53","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3748\/wjg.v19.i6.874","article-title":"Intraductal Ultrasound Substantiates Diagnostics of Bile Duct Strictures of Uncertain Etiology","volume":"19","author":"Meister","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-123186","article-title":"EUS-FNA Versus ERCP for Tissue Diagnosis of Suspect Malignant Biliary Strictures: A Prospective Comparative Study","volume":"6","author":"Moura","year":"2018","journal-title":"Endosc Int Open"},{"key":"B55","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/eus.eus_24_19","article-title":"The Incremental Benefit of EUS for the Identification of Malignancy in Indeterminate Extrahepatic Biliary Strictures: A Systematic Review and Meta-Analysis","volume":"8","author":"Chiang","year":"2019","journal-title":"Endosc Ultrasound"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1034","article-title":"Tissue Acquisition for Diagnosis of Biliary Strictures Using Peroral Cholangioscopy or Endoscopic Ultrasound-Guided Fine-Needle Aspiration","volume":"51","author":"Lee","year":"2019","journal-title":"Endoscopy"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1159\/000481235","article-title":"Needle Tract Seeding: An Overlooked Rare Complication of Endoscopic Ultrasound-Guided Fine-Needle Aspiration","volume":"93","author":"Minaga","year":"2017","journal-title":"Oncology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.80","article-title":"Prospective Cytological Assessment of Gastrointestinal Luminal Fluid Acquired During EUS: A Potential Source of False-Positive FNA and Needle Tract Seeding","volume":"105","author":"Levy","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(03)02009-1","article-title":"Lower Frequency of Peritoneal Carcinomatosis in Patients With Pancreatic Cancer Diagnosed by EUS-Guided FNA vs. Percutaneous FNA","volume":"58","author":"Micames","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/den.13615","article-title":"Non-Negligible Rate of Needle Tract Seeding After Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Patients Undergoing Distal Pancreatectomy for Pancreatic Cancer","volume":"32","author":"Yane","year":"2020","journal-title":"Dig Endosc"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307475","article-title":"Preoperative Endoscopic Ultrasound-Guided Fine Needle Aspiration Does Not Impair Survival of Patients With Resected Pancreatic Cancer","volume":"64","author":"Ngamruengphong","year":"2015","journal-title":"Gut"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1344760","article-title":"Impact of Preoperative Endoscopic Ultrasound-Guided Fine Needle Aspiration on Postoperative Recurrence and Survival in Cholangiocarcinoma Patients","volume":"45","author":"Chafic","year":"2013","journal-title":"Endoscopy"},{"key":"B63","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/diagnostics10050337","article-title":"The Diagnostic Dilemma of Malignant Biliary Strictures","volume":"10","author":"Dorrell","year":"2020","journal-title":"Diagnostics"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30281.x","article-title":"A Comparison of Routine Cytology and Fluorescence In Situ Hybridization for the Detection of Malignant Bile Duct Strictures","volume":"99","author":"Kipp","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.046","article-title":"An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples","volume":"149","author":"Barr Fritcher","year":"2015","journal-title":"Gastroenterology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.895040","article-title":"Diagnostic Accuracy of Serum CA19-9 in Patients With Cholangiocarcinoma: A Systematic Review and Meta-Analysis","volume":"21","author":"Liang","year":"2015","journal-title":"Med Sci Monit"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.12688\/f1000research.11371.1","article-title":"Novel Biomarkers and Endoscopic Techniques for Diagnosing Pancreaticobiliary Malignancy","volume":"6","author":"Keane","year":"2017","journal-title":"F1000Research"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13929","article-title":"Serum and Tissue Markers in Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical and Prognostic Implications","volume":"8","author":"Berretta","year":"2017","journal-title":"Oncotarget"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.02.007","article-title":"Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma","volume":"9","author":"Sinakos","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of Endoscopy in Primary Sclerosing Cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline","volume":"49","author":"Aabakken","year":"2017","journal-title":"Endoscopy"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC Guidelines for the Diagnosis and Management of Primary Sclerosing Cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2018.02.008","article-title":"The Diagnostic Value of Five Serum Tumor Markers for Patients With Cholangiocarcinoma","volume":"480","author":"Qiu","year":"2018","journal-title":"Clin Chim Acta"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1159\/000335164","article-title":"Pathobiological Implications of MUC16\/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type","volume":"79","author":"Higashi","year":"2012","journal-title":"Pathobiology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/02841850802220092","article-title":"Detection of Cholangiocarcinoma With Magnetic Resonance Spectroscopy of Bile in Patients With and Without Primary Sclerosing Cholangitis","volume":"49","author":"Albiin","year":"2008","journal-title":"Acta Radiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12929-019-0599-5","article-title":"Bile and Urine Peptide Marker Profiles: Access Keys to Molecular Pathways and Biological Processes in Cholangiocarcinoma","volume":"27","author":"Voigtl\u00e4nder","year":"2020","journal-title":"J BioMed Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3390\/cancers12061644","article-title":"Pilot Multi-Omic Analysis of Human Bile From Benign and Malignant Biliary Strictures: A Machine-Learning Approach","volume":"12","author":"Urman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.447","article-title":"Diagnosis of Pancreaticobiliary Malignancy by Detection of Minichromosome Maintenance Protein 5 in Biliary Brush Cytology","volume":"116","author":"Keane","year":"2017","journal-title":"Br J Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2008.01.011","article-title":"Diagnostic Role of Biliary Pancreatic Elastase for Cholangiocarcinoma in Patients With Cholestasis","volume":"390","author":"Chen","year":"2008","journal-title":"Clin Chim Acta"},{"key":"B79","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/hep.27050","article-title":"Human Bile Contains MicroRNA-Laden Extracellular Vesicles That Can Be Used for Cholangiocarcinoma Diagnosis","volume":"60","author":"Li","year":"2014","journal-title":"Hepatology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2017.04.043","article-title":"Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses","volume":"153","author":"Severino","year":"2017","journal-title":"Gastroenterology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/mc.21859","article-title":"Ars2 Is Overexpressed in Human Cholangiocarcinomas and Its Depletion Increases PTEN and PDCD4 by Decreasing microRNA-21","volume":"52","author":"He","year":"2013","journal-title":"Mol Carcinog"},{"key":"B82","doi-asserted-by":"publisher","first-page":"105775","DOI":"10.1016\/j.jsbmb.2020.105775","article-title":"Analysis of Bile Acid Profile in Plasma to Differentiate Cholangiocarcinoma From Benign Biliary Diseases and Healthy Controls","volume":"205","author":"Zhang","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3349\/ymj.2006.47.6.817","article-title":"Bile Acid Analysis in Biliary Tract Cancer","volume":"47","author":"Park","year":"2006","journal-title":"Yonsei Med J"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0217-8","article-title":"Metabolic Rearrangements in Primary Liver Cancers: Cause and Consequences","volume":"16","author":"Satriano","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"11088","DOI":"10.1038\/s41598-018-29445-z","article-title":"Discovery of Glycocholic Acid and Taurochenodeoxycholic Acid as Phenotypic Biomarkers in Cholangiocarcinoma","volume":"8","author":"Song","year":"2018","journal-title":"Sci Rep"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27085","article-title":"Conjugated Bile Acids Promote Cholangiocarcinoma Cell Invasive Growth Through Activation of Sphingosine 1-Phosphate Receptor 2","volume":"60","author":"Liu","year":"2014","journal-title":"Hepatology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32410","article-title":"Bile Acids Induce Cyclooxygenase-2 Expression via the Epidermal Growth Factor Receptor in a Human Cholangiocarcinoma Cell Line","volume":"122","author":"Yoon","year":"2002","journal-title":"Gastroenterology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/164_2019_230","article-title":"Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors","volume":"256","author":"Keitel","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.08.016","article-title":"Differential Effects of FXR or TGR5 Activation in Cholangiocarcinoma Progression","volume":"1864","author":"Erice","year":"2018","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"B90","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/hep.30852","article-title":"Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma","volume":"71","author":"Jia","year":"2020","journal-title":"Hepatology"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24103","article-title":"Bile Proteomic Profiles Differentiate Cholangiocarcinoma From Primary Sclerosing Cholangitis and Choledocholithiasis","volume":"53","author":"Lankisch","year":"2011","journal-title":"Hepatology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2015.02.005","article-title":"Endoscopic Diagnosis of Cholangiocarcinoma: From Endoscopic Retrograde Cholangiography to Bile Proteomics","volume":"29","author":"Voigtl\u00e4nder","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21294","article-title":"Proteomic Profiling of Cholangiocarcinoma: Diagnostic Potential of SELDI-TOF MS in Malignant Bile Duct Stricture","volume":"44","author":"Scarlett","year":"2006","journal-title":"Hepatology"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.68.1.649","article-title":"MCM Proteins in DNA Replication","volume":"68","author":"Tye","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2010.03.005","article-title":"Transcriptional Induction of Minichromosome Maintenance Protein 7 (Mcm7) in Human Cholangiocarcinoma Cells Treated With Clonorchis Sinensis Excretory\u2013Secretory Products","volume":"173","author":"Kim","year":"2010","journal-title":"Mol Biochem Parasitol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209134","article-title":"MCM7 Amplification and Overexpression Are Associated With Prostate Cancer Progression","volume":"25","author":"Ren","year":"2006","journal-title":"Oncogene"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604342","article-title":"Diagnosis of Pancreaticobiliary Malignancy by Detection of Minichromosome Maintenance Protein 5 in Bile Aspirates","volume":"98","author":"Ayaru","year":"2008","journal-title":"Br J Cancer"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/s41598-021-81023-y","article-title":"Utility of Claudin-3 in Extracellular Vesicles From Human Bile as Biomarkers of Cholangiocarcinoma","volume":"11","author":"Ikeda","year":"2021","journal-title":"Sci Rep"},{"key":"B99","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological Properties of Extracellular Vesicles and Their Physiological Functions","volume":"4","author":"Yanez-Mo","year":"2015","journal-title":"J Extracell vesicles"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.10.009","article-title":"Extracellular Vesicles in Cancer: Cell-To-Cell Mediators of Metastasis","volume":"30","author":"Becker","year":"2016","journal-title":"Cancer Cell"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02270","article-title":"Extracellular Vesicles in Hepatobiliary Malignancies","volume":"9","author":"Lapitz","year":"2018","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1758835920953293","DOI":"10.1177\/1758835920953293","article-title":"FGFR Inhibitors in Cholangiocarcinoma: What\u2019s Now and What\u2019s Next","volume":"12","author":"Saborowski","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma: A Multicentre, Open-Label, Phase 2 Study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent Mutation of Isocitrate Dehydrogenase (IDH) 1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"key":"B106","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1470-2045(20)30214-X","article-title":"Towards Greater Clarity in the Treatment of Cholangiocarcinoma","volume":"21","author":"de la Fouchardiere","year":"2020","journal-title":"Lancet Oncol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12253-018-0491-8","article-title":"Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis","volume":"26","author":"Lendvai","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X17698090","article-title":"The Potential Role of Comprehensive Genomic Profiling to Guide Targeted Therapy for Patients With Biliary Cancer","volume":"10","author":"Lee","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29764","article-title":"Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic Cholangiocarcinoma","volume":"68","author":"Nepal","year":"2018","journal-title":"Hepatology"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3375","article-title":"Genomic Spectra of Biliary Tract Cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20031","article-title":"MUC4 Is a Novel Prognostic Factor of Intrahepatic Cholangiocarcinoma-Mass Forming Type","volume":"39","author":"Shibahara","year":"2004","journal-title":"Hepatology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300609","article-title":"Expression of MUC1 and MUC2 Mucin Antigens in Intrahepatic Bile Duct Tumors: Its Relationship With a New Morphological Classification of Cholangiocarcinoma","volume":"30","author":"Higashi","year":"1999","journal-title":"Hepatology"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2010.08.004","article-title":"The Expression of MUC Mucin in Cholangiocarcinoma","volume":"206","author":"Mall","year":"2010","journal-title":"Pathol - Res Pract"},{"key":"B114","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1245\/s10434-013-3286-x","article-title":"Prognostic Biomarkers in Patients With Resected Cholangiocarcinoma: A Systematic Review and Meta-Analysis","volume":"21","author":"Ruys","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.452","article-title":"E\/N-Cadherin Switch Mediates Cancer Progression via TGF-\u03b2-Induced Epithelial-to-Mesenchymal Transition in Extrahepatic Cholangiocarcinoma","volume":"105","author":"Araki","year":"2011","journal-title":"Br J Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2087-6","article-title":"Loss of E-Cadherin Promotes Migration and Invasion of Cholangiocarcinoma Cells and Serves as a Potential Marker of Metastasis","volume":"35","author":"Techasen","year":"2014","journal-title":"Tumor Biol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26399","article-title":"Clinical Correlation of Cadherin-17 Marker With Advanced Tumor Stages and Poor Prognosis of Cholangiocarcinoma","volume":"123","author":"Zheng","year":"2021","journal-title":"J Surg Oncol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072386","article-title":"Anti-Cadherin-17 Antibody Modulates Beta-Catenin Signaling and Tumorigenicity of Hepatocellular Carcinoma. Lee JW, Editor","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0404-OA","article-title":"CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2","volume":"141","author":"Altree-Tacha","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19044","article-title":"miRNA and lncRNA as Biomarkers in Cholangiocarcinoma(CCA)","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3390\/biom10101396","article-title":"The Emerging Role of MicroRNAs in Regulating the Drug Response of Cholangiocarcinoma","volume":"10","author":"Huang","year":"2020","journal-title":"Biomolecules"},{"key":"B122","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3390\/cells9040832","article-title":"Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids","volume":"9","author":"Amato","year":"2020","journal-title":"Cells"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22838","article-title":"MicroRNA-21 Is Overexpressed in Human Cholangiocarcinoma and Regulates Programmed Cell Death 4 and Tissue Inhibitor of Metalloproteinase 3","volume":"49","author":"Selaru","year":"2009","journal-title":"Hepatology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mc.21864","article-title":"Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma and Its Prognostic Significance","volume":"52","author":"Karakatsanis","year":"2013","journal-title":"Mol Carcinog"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-013-0688-0","article-title":"Overexpression of microRNA-21 Regulating PDCD4 During Tumorigenesis of Liver Fluke-Associated Cholangiocarcinoma Contributes to Tumor Growth and Metastasis","volume":"34","author":"Chusorn","year":"2013","journal-title":"Tumor Biol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.06.020","article-title":"Elevated Levels of Circulating Osteopontin Are Associated With a Poor Survival After Resection of Cholangiocarcinoma","volume":"67","author":"Loosen","year":"2017","journal-title":"J Hepatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1600141","DOI":"10.1002\/prca.201600141","article-title":"Identification of Fucosylated Fetuin-A as a Potential Biomarker for Cholangiocarcinoma","volume":"11","author":"Betesh","year":"2017","journal-title":"PROTEOMICS\u2013Clinical Appl"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01403.x","article-title":"Diagnostic Utility of Interleukin-6 (IL-6) for Primary Bile Duct Cancer and Changes in Serum IL-6 Levels Following Photodynamic Therapy","volume":"102","author":"Cheon","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/medicina56110616","article-title":"Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma","volume":"56","author":"Luang","year":"2020","journal-title":"Medicina (B Aires)"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2020.200212","article-title":"The Role of Resolvin D1 in the Differential Diagnosis of the Cholangiocarcinoma and Benign Biliary Diseases","volume":"66","author":"G\u00fcl-Utku","year":"2020","journal-title":"Clin Lab"},{"key":"B132","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-230X-9-30","article-title":"Detection of Serum MMP-7 and MMP-9 in Cholangiocarcinoma Patients: Evaluation of Diagnostic Accuracy","volume":"9","author":"Leelawat","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"B133","article-title":"Measurement of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Cytokeratin-19 Fragment and Matrix Metalloproteinase-7 for Detecting Cholangiocarcinoma: A Preliminary Case-Control Study","volume":"34","author":"Lumachi","year":"2014","journal-title":"Anticancer Res"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24732","article-title":"Identification of a Serum Biomarker Panel for the Differential Diagnosis of Cholangiocarcinoma and Primary Sclerosing Cholangitis","volume":"9","author":"Cuenco","year":"2018","journal-title":"Oncotarget"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1177\/000313481007601119","article-title":"Comparison of Serum Tumor Markers for Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma","volume":"76","author":"Tao","year":"2010","journal-title":"Am Surg"},{"key":"B136","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clinbiochem.2020.02.009","article-title":"Diagnostic Value of Serum Glypican-3 Alone and in Combination With AFP as an Aid in the Diagnosis of Liver Cancer","volume":"79","author":"Liu","year":"2020","journal-title":"Clin Biochem"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.07.017","article-title":"Multi-Serum Glycobiomarkers Improves the Diagnosis and Prognostic Prediction of Cholangiocarcinoma","volume":"510","author":"Silsirivanit","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1010428318767195","DOI":"10.1177\/1010428318767195","article-title":"Proteomics Detection of S100A6 in Tumor Tissue Interstitial Fluid and Evaluation Of Its Potential as a Biomarker of Cholangiocarcinoma","volume":"40","author":"Onsurathum","year":"2018","journal-title":"Tumour Biol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/cncr.27788","article-title":"High Expression of Dickkopf-Related Protein 1 Is Related to Lymphatic Metastasis and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma Patients After Surgery","volume":"119","author":"Shi","year":"2013","journal-title":"Cancer"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047476","article-title":"Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma","volume":"7","author":"Shen","year":"2012","journal-title":"PloS One"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e0163699","DOI":"10.1371\/journal.pone.0163699","article-title":"Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma","volume":"11","author":"Correa-Gallego","year":"2016","journal-title":"PloS One"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12300","article-title":"Plasma Mi R-21 Is a Novel Diagnostic Biomarker for Biliary Tract Cancer","volume":"104","author":"Kishimoto","year":"2013","journal-title":"Cancer Sci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S297371","article-title":"Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer","volume":"14","author":"Han","year":"2021","journal-title":"Int J Gen Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e23397","DOI":"10.1002\/jcla.23397","article-title":"The Association Between Circulating MicroRNA-150 Level and Cholangiocarcinoma","volume":"34","author":"Salem","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"B145","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/cei.12776","article-title":"Serum microRNAs as Novel Biomarkers for Primary Sclerosing Cholangitis and Cholangiocarcinoma","volume":"185","author":"Bernuzzi","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"e0139305","DOI":"10.1371\/journal.pone.0139305","article-title":"MicroRNAs in Serum and Bile of Patients With Primary Sclerosing Cholangitis and\/or Cholangiocarcinoma","volume":"10","author":"Voigtlander","year":"2015","journal-title":"PloS One"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(01)00265-X","article-title":"Serum Total Sialic Acid in Cholangiocarcinoma Patients: An ROC Curve Analysis","volume":"34","author":"Wongkham","year":"2001","journal-title":"Clin Biochem"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i10.2178","article-title":"Role of Serum Total Sialic Acid in Differentiating Cholangiocarcinoma From Hepatocellular Carcinoma","volume":"9","author":"Kongtawelert","year":"2003","journal-title":"World J Gastroenterol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1039\/C5MB00572H","article-title":"Serum Metabolomics Uncovering Specific Metabolite Signatures of Intra- and Extrahepatic Cholangiocarcinoma","volume":"12","author":"Liang","year":"2016","journal-title":"Mol Biosyst"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29291","article-title":"Serum Extracellular Vesicles Contain Protein Biomarkers for Primary Sclerosing Cholangitis and Cholangiocarcinoma","volume":"66","author":"Arbelaiz","year":"2017","journal-title":"Hepatology"},{"key":"B151","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/cells9030721","article-title":"Patients With Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis","volume":"9","author":"Lapitz","year":"2020","journal-title":"Cells"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.02.024","article-title":"Cancer-Associated Circulating Large Extracellular Vesicles in Cholangiocarcinoma and Hepatocellular Carcinoma","volume":"67","author":"Julich-Haertel","year":"2017","journal-title":"J Hepatol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","article-title":"The Multiple Functions and Mechanisms of Osteopontin","volume":"59","author":"Icer","year":"2018","journal-title":"Clin Biochem"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311739","article-title":"Anti-GP2 IgA Autoantibodies Are Associated With Poor Survival and Cholangiocarcinoma in Primary Sclerosing Cholangitis","volume":"66","author":"Jendrek","year":"2017","journal-title":"Gut"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2018.12.006","article-title":"Serum CA50 Levels in Patients With Cancers and Other Diseases","volume":"162","author":"Shan","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e0238251","DOI":"10.1371\/journal.pone.0238251","article-title":"Plasma Proteome Atlas for Differentiating Tumor Stage and Post-Surgical Prognosis of Hepatocellular Carcinoma and Cholangiocarcinoma","volume":"15","author":"Chang","year":"2020","journal-title":"PloS One"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.04.010","article-title":"Afamin\u2014a Pleiotropic Glycoprotein Involved in Various Disease States","volume":"446","author":"Dieplinger","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid Biopsy: Monitoring Cancer-Genetics in the Blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.21873\/cgp.20203","article-title":"Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives","volume":"17","author":"Rizzo","year":"2020","journal-title":"Cancer Genomics - Proteomics"},{"key":"B160","doi-asserted-by":"publisher","first-page":"e0200717","DOI":"10.1371\/journal.pone.0200717","article-title":"Potential Biomarkers and Therapeutic Targets in Cervical Cancer: Insights From the Meta-Analysis of Transcriptomics Data Within Network Biomedicine Perspective","volume":"13","author":"Kori","year":"2018","journal-title":"PloS One"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3727\/105221614X13919976902174","article-title":"Emerging Insights Into the Role of microRNAs in the Pathogenesis of Cholangiocarcinoma","volume":"16","author":"Haga","year":"2014","journal-title":"Gene Expr J Liver Res"},{"key":"B162","article-title":"Increased Expression of miR-21 Predicts Poor Prognosis in Patients With Hepatocellular Carcinoma","volume":"8","author":"Huang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3641","article-title":"Upregulated Circulating miR-150 Is Associated With the Risk of Intrahepatic Cholangiocarcinoma","volume":"33","author":"Wang","year":"2015","journal-title":"Oncol Rep"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5313-6","article-title":"Profiling of Downregulated Blood-Circulating miR-150-5p as a Novel Tumor Marker for Cholangiocarcinoma","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"16103","DOI":"10.1038\/srep16103","article-title":"Circulating miR-106a Is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci Rep"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2459","article-title":"Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients With Hepatocellular Carcinoma","volume":"78","author":"Qi","year":"2018","journal-title":"Cancer Res"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13640","article-title":"A Panel Consisting of Three Novel Circulating lncRNAs, Is It a Predictive Tool for Gastric Cancer","volume":"22","author":"Liu","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2018.1480292","article-title":"Pancreatic and Bile Duct Cancer Circulating Tumor Cells (CTC) Form Immune-Resistant Multi-Cell Type Clusters in the Portal Venous Circulation","volume":"19","author":"Arnoletti","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70069-5","article-title":"Clinical Validity of Circulating Tumour Cells in Patients With Metastatic Breast Cancer: A Pooled Analysis of Individual Patient Data","volume":"15","author":"Bidard","year":"2014","journal-title":"Lancet Oncol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1007\/s11888-016-0320-y","article-title":"Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons","volume":"12","author":"Tan","year":"2016","journal-title":"Curr Colorectal Cancer Rep"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/nature06385","article-title":"Isolation of Rare Circulating Tumour Cells in Cancer Patients by Microchip Technology","volume":"450","author":"Nagrath","year":"2007","journal-title":"Nature"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25758","article-title":"EpCAM- and EGFR-Targeted Selective Gene Therapy for Biliary Cancers Using Z33-Fiber-Modified Adenovirus","volume":"129","author":"Kawashima","year":"2011","journal-title":"Int J Cancer"},{"key":"B173","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3978\/j.issn.2078-6891.2011.047","article-title":"Detection of Circulating Tumor Cells in Cancers of Biliary Origin","volume":"3","author":"Al Ustwani","year":"2012","journal-title":"J Gastrointest Oncol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0378","article-title":"Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas But Not in Healthy Subjects or Patients With Nonmalignant Diseases","volume":"10","author":"Allard","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27944","article-title":"Circulating Tumor Cells Are Associated With Poor Overall Survival in Patients With Cholangiocarcinoma","volume":"63","author":"Yang","year":"2016","journal-title":"Hepatology"},{"key":"B176","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41416-018-0132-8","article-title":"Circulating Biomarkers During Treatment in Patients With Advanced Biliary Tract Cancer Receiving Cediranib in the UK ABC-03 Trial","volume":"119","author":"Backen","year":"2018","journal-title":"Br J Cancer"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3596-x","article-title":"Volatile Organic Compounds in Urine for Noninvasive Diagnosis of Malignant Biliary Strictures: A Pilot Study","volume":"60","author":"Navaneethan","year":"2015","journal-title":"Dig Dis Sci"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1002\/prca.200700035","article-title":"Recent Progress in Urinary Proteomics","volume":"1","author":"Thongboonkerd","year":"2007","journal-title":"Proteomics \u2013 Clin Appl"},{"key":"B179","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/14789450.2018.1547193","article-title":"Urinary Proteomic Biomarkers in Oncology: Ready for Implementation","volume":"16","author":"Frantzi","year":"2019","journal-title":"Expert Rev Proteomics"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302047","article-title":"Urine Proteomic Analysis Differentiates Cholangiocarcinoma From Primary Sclerosing Cholangitis and Other Benign Biliary Disorders","volume":"62","author":"Metzger","year":"2013","journal-title":"Gut"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1177\/2050640616687836","article-title":"A Combined Bile and Urine Proteomic Test for Cholangiocarcinoma Diagnosis in Patients With Biliary Strictures of Unknown Origin","volume":"5","author":"Voigtl\u00e4nder","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2015.10.001","article-title":"Urinary microRNA-192 and microRNA-21 as Potential Indicators for Liver Fluke-Associated Cholangiocarcinoma Risk Group","volume":"66","author":"Silakit","year":"2017","journal-title":"Parasitol Int"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.17-0879","article-title":"Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review","volume":"98","author":"Tshering","year":"2018","journal-title":"Am J Trop Med Hyg"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.699401\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T15:47:31Z","timestamp":1633016851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.699401\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":183,"alternative-id":["10.3389\/fonc.2021.699401"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.699401","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"article-number":"699401"}}